氟替卡松气雾剂联合维生素AD预防婴幼儿毛细支气管炎后哮喘的疗效观察  

Therapeutic effect of flixotide combined with vitamin AD in prevention of asthma following bronchiolitis

作　　者：林莉[1] 王桂兰[1] 

机构地区：[1]四川省自贡市第一人民医院儿科,四川自贡643000

出　　处：《实用医院临床杂志》2014年第5期163-165,共3页Practical Journal of Clinical Medicine

摘　　要：目的观察氟替卡松气雾剂联合维生素AD预防婴幼儿毛细支气管炎后哮喘的疗效。方法将90例毛细支气管炎患儿采用随机数字表法分为治疗组46例与对照组44例,两组均采用氟替卡松气雾剂吸入预防,治疗组在此基础上加用维生素AD滴剂口服,疗程1年,临床随访2年,观察两组患儿哮喘的发生情况。结果治疗组毛细支气管炎后哮喘的发生率明显低于对照组,差异有统计学意义(P<0.05)。结论氟替卡松气雾剂联合维生素AD可明显降低婴幼儿毛细支气管炎后哮喘的发生率,且费用低廉,值得临床推广。Objective To evaluate the efficiency of flixotide combined with vitamin AD in decreasing the incidence of asthma following bronchiolitis .Methods Ninety children with bronchiolitis were randomly divided into treatment group （ n =46 ） and control group （n =44）.Both groups were treated with flixotide propionate aerosol inhalation ,but the treatment group was combined with oral vitamin AD drops.The intervention duration was 1-year and the incidence of asthma was observed during a 2-year clinical follow-up. Results The incidence of bronchiolitis asthma in the treatment group was significantly lower than that in the control group （ P 〈0.05 ） .Conclusion Flixotide combined with vitamin AD can significantly reduce the prevalence of asthma after bronchiolitis in in -fants.

关 键 词：氟替卡松气雾剂 维生素AD 毛细支气管炎 哮喘 

分 类 号：R562.21[医药卫生—呼吸系统] R256.12[医药卫生—内科学]